Recognising increased risk of melanoma Mass screening is not cost-effective, but effort should be made to identify patients at high risk. By Dr Joy Osborne Sign in to continue Sign In Email address Password Stay signed in Trouble signing in? Reset password: Click here Need help? Email us Register FREE Limited free articles a month Free email bulletins Register Now Subscribe now Benefits include: Full site access Subscriber exclusive content Exclusive bulletins Choose a package